Cargando…

Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer

PURPOSE: This study aimed to investigate the clinical utility of diverse aneuploid circulating tumor cell (CTC) subtypes and particularly CTC-associated white blood cell (CTC-WBC) clusters in predicting treatment response, prognosis and real-time monitoring disease progression in advanced driver gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying, Liu, Yanxia, Zhang, Zhiyun, Lu, Baohua, Gao, Yuan, Tong, Li, Hu, Mingming, Lin, Peter Ping, Li, Baolan, Zhang, Tongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286386/ https://www.ncbi.nlm.nih.gov/pubmed/37349714 http://dx.doi.org/10.1186/s12885-023-10985-1

Ejemplares similares

Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer
por: Wang, Ying, et al.
Publicado: (2019)

Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients
por: Zhao, Cong, et al.
Publicado: (2022)

Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer
por: Zhao, Cong, et al.
Publicado: (2023)

A single center analysis of first-line treatment in advanced KRAS mutant non-small cell lung cancer: real-world practice
por: Liu, Yanxia, et al.
Publicado: (2022)

Topoisomerase I expression is associated with prognosis in postoperative non‐small cell lung cancer patients
por: Lu, Baohua, et al.
Publicado: (2016)

Role of aneuploid circulating tumor cells and CD31(+) circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC
por: Zhang, Tongmei, et al.
Publicado: (2021)

Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
por: Hu, Aimin, et al.
Publicado: (2023)

Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma
por: Luo, Qiong, et al.
Publicado: (2020)

Mutation status analysis of 58 patients with advanced ALK fusion gene positive non small cell lung cancer
por: Yang, Yuan, et al.
Publicado: (2023)

Association of circulating tumor cell-white blood cell clusters with survival outcomes in patients with colorectal cancer after curative intent surgery
por: Xu, Yifan, et al.
Publicado: (2022)

Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma
por: Tian, Cuimeng, et al.
Publicado: (2020)

Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method
por: Tian, Cuimeng, et al.
Publicado: (2023)

High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China
por: Li, Jisen, et al.
Publicado: (2018)

Comprehensive Comparative Molecular Characterization of Young and Old Lung Cancer Patients
por: Hu, Mingming, et al.
Publicado: (2022)

Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review
por: Zheng, Hua, et al.
Publicado: (2016)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer
por: Qian, Zhe, et al.
Publicado: (2018)

Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer
por: Guan, Xiuwen, et al.
Publicado: (2021)

The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma
por: Guan, Yibing, et al.
Publicado: (2021)

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer
por: Feng, Yu, et al.
Publicado: (2022)

The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer
por: He, Jiabei, et al.
Publicado: (2016)

Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer
por: Lim, Minji, et al.
Publicado: (2021)

Serum bilirubin is negatively associated with white blood cell count
por: Zhang, Li, et al.
Publicado: (2019)

Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer
por: Li, Man, et al.
Publicado: (2014)

Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
por: He, Jiabei, et al.
Publicado: (2015)

Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy
por: Wen, Yue-Feng, et al.
Publicado: (2018)

Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma
por: Wang, Chunming, et al.
Publicado: (2021)

Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer
por: Feng, Fan, et al.
Publicado: (2016)

The lnc-SNHG1 Gene Is Overexpressed and Correlates with Increased White Blood Cell Count, Poor Induction Treatment Response, and Poor Survival Profile in Adult Acute Myeloid Leukemia
por: Zeng, Pengyun, et al.
Publicado: (2022)

Survival Mechanisms and Influence Factors of Circulating Tumor Cells
por: Wang, Wen-Chao, et al.
Publicado: (2018)

Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival
por: Balakrishnan, Ajay, et al.
Publicado: (2019)

Low Preoperative albumin-to-globulin ratio Predict Poor Survival and Negatively Correlated with Fibrinogen in Resectable Esophageal Squamous Cell Carcinoma
por: Li, Xiao-Hui, et al.
Publicado: (2017)

Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer
por: Berg, Janna, et al.
Publicado: (2022)

Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer
por: Yi-Wen, Wang, et al.
Publicado: (2022)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
por: Ou, Guoping, et al.
Publicado: (2019)

Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer
por: Berg, Janna, et al.
Publicado: (2022)

High Expression of GSDMC Is Associated with Poor Survival in Kidney Clear Cell Cancer
por: Cui, Yun-Qian, et al.
Publicado: (2021)

White Blood Cell Segmentation by Color-Space-Based K-Means Clustering
por: Zhang, Congcong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rdnvd5li3jn6dloklu3r7klk81